ALKS Alkermes Plc.

$44.90 +0.85%

Healthcare · Pharmaceutical Preparations

Alkermes Plc. (ALKS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $7.5 billion. Shares last traded at $44.90, near their 52-week high. Over the past year the stock is up 50.8%. ALKS trades at a price-to-earnings ratio of 30.96, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 16.4%, above the peer median of -0.1%. Revenue declined 5.2% year over year.

Market Cap

$7.5B

Shares Out

166.7M

EPS (TTM)

$1.52

P/E Ratio

29.54

P/S Ratio

5.07

P/B Ratio

4.27

Dividend / Share

—

Dividend Yield

—

52-Week High

$45.79

52-Week Low

$25.16

Volume

122,552

Avg Vol (3m)

146,978.841

Performance

-0.13%

+21.37%

+58.07%

+60.04%

YTD

+58.91%

+50.82%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

70.50

SMA (50)

$37.84

SMA (200)

$32.18

Price vs SMA50

+18.65%

Price vs SMA200

+39.53%

ATR (14)

$1.93

Financials

Revenue

$1.5B

Net Income

$242M

Gross Margin

—

Operating Margin

17.2%

Net Margin

16.4%

Return on Equity

13.8%

Return on Assets

5.7%

Current Ratio

2.27

Debt / Equity

0.87

Revenue Growth (YoY)

-5.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.40	2026-05-05
FY 2025	$1.43	2026-02-25
Q3 2025	$1.14	2025-10-28
Q2 2025	$0.65	2025-07-29
Q1 2026	$0.13	2026-05-05
FY 2025	$2.17	2026-02-25

Full earnings history →

Pharmaceutical Preparations peers

ALKS vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

30.96 / 16.82 med

+84% premium

P/S vs peers

5.07 / 3.54 med

+43% premium

Net margin vs peers

16.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.